Background Bone stress injuries are common in high-level athletics.
Aim To describe the demographics, frequency and anatomical location of stress injuries (ie, stress reaction and stress fractures) in athletes at the Rio de Janeiro 2016 Summer Olympic Games.
Methods We recorded all sports injuries at the Rio de Janeiro 2016 Summer Olympics reported by the National Olympic Committee (NOC) medical teams and in the polyclinic and medical venues. Imaging was performed through the official IOC clinic within the Olympic Village, using digital X-ray cameras and 3T and 1.5T magnetic resonance (MR) scanners. Images were read centrally and retrospectively by musculoskeletal radiologists with expertise in sports injuries.
Results 11 274 athletes (5089 women (45%), 6185 men (55%)) from 207 NOCs participated in the study. 1101 injuries were reported. Imaging revealed 9 stress fractures (36%) and 16 stress reactions (64%) in 18 female and 7 male athletes (median age 25 years, age range 18–32). Stress injuries were mostly in the lower extremities (84%), particularly tibia (44%) and metatarsals (12%), with two in the lumbar spine (8%). Stress injuries were most common in track and field athletes (44%) followed by volleyball players (16%), gymnastics (artistic) (12%) and other type of sports.
Conclusions Twenty-five bone stress injuries were reported, more commonly in women, mostly in the lower extremities and most commonly in track and field athletes. Our study demonstrates the importance of early imaging with MRI to detect stress reactions before they can progress to stress fractures.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Competing interests Ali Guermazi is the President of Boston ImagingCore Lab (BICL), LLC, and a Consultant to MerckSerono, AstraZeneca, Pfizer, GEHealthcare, OrthoTrophix, Sanofi and TissueGene. Frank Roemer and Michel Cremaare shareholders of BICL, LLC. Lars Engebretsen is a consultant to Arthrex andSmith and Nephew. The remaining authors have no conflicts of interest to disclose.
Ethics approval The research was approved by IOC as well as ethics committee of South-Eastern Norway Regional Health Authority (#S-07196C).
Provenance and peer review Commissioned; externally peer reviewed.
Data sharing statement Unpublished data are not available for sharing.
Correction notice This article has been corrected since it was published Online First. One affiliation has been corrected.